CD19 and B-cell chronic lymphocytic leukemia: Additional rare cases of lineage switching include CLL transforming into plasmablastic lymphoma and MCL undergoing transdifferentiation into sarcoma following anti-CD19 CAR T-cell therapy [69,70].